Market Update (NYSE:BSX): Boston Scientific To Participate In 2016 J.P. Morgan Healthcare Conference

[PR Newswire] – MARLBOROUGH, Mass., Dec. 22, 2015 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 34 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 … Read more on this. Boston Scientific Corporation (BSX) , with a current value of $24.36B, began trading this morning at $18.37. Today, shares have traded between $18.02 and $18.40 per share with the price of the stock fluctuating between $12.93 to $19.06 over the last 52 weeks. Priced at 19.86x this year’s forecasted earnings, BSX shares are relatively expensive compared to the industry’s 5.00x forward p/e ratio. In a review of the consensus earnings estimate this quarter, 24 sell-side analysts are looking at $0.25 per share, which would be $0.03 better than the year-ago quarter and a $0.01 sequential decrease. The full-year EPS estimate is $0.92, which would be a $0.08 better than last year. The quarterly earnings estimate is predicated on a consensus revenue forecast of $2.00 Billion. If reported, that would be a 5.82% increase over the year-ago quarter. In terms of ratings, Needham upgraded BSX from Hold to Buy (Sep 28, 2015). Previously, Goldman upgraded BSX from Neutral to Buy. The average price target for BSX shares by the analysts covering the stock is $20.85, which is 13.50% above where the stock opened this morning. See more in (NYSE:BSX) Similar Articles: Market Update (NYSE:BSX): Boston Scientific To Participate In Stifel Healthcare Conference Company Update (NYSE:BSX): Boston Scientific To Participate In 2015 Morgan Stanley Global Healthcare Conference Company Update (NYSE:BSX): Boston Scientific To Participate In The 2015 Wells Fargo Healthcare Conference